Cargando…

Biomarkers of Cutaneous Leishmaniasis

Cutaneous leishmaniasis (CL) is an immune-mediated skin pathology caused mainly by Leishmania (L.) major, Leishmania tropica, Leishmania braziliensis, L. mexicana, and L. amazonensis. The burden of CL in terms of morbidity and social stigmas are concentrated on certain developing countries in Asia,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bahrami, Fariborz, Harandi, Ali M., Rafati, Sima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029629/ https://www.ncbi.nlm.nih.gov/pubmed/29998089 http://dx.doi.org/10.3389/fcimb.2018.00222

Ejemplares similares

Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
por: Volpedo, Greta, et al.
Publicado: (2021)

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control
por: Noronha, Letícia Paula Trajano, et al.
Publicado: (2023)

Editorial: Biomarkers in Leishmaniasis
por: Carrillo, Eugenia, et al.
Publicado: (2019)

Editorial: Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches
por: Pavanelli, Wander Rogério, et al.
Publicado: (2022)

Immunomodulation From Moderate Exercise Promotes Control of Experimental Cutaneous Leishmaniasis
por: Terra, Rodrigo, et al.
Publicado: (2019)

Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms
por: Rizk, Yasmin Silva, et al.
Publicado: (2021)

Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
por: Brodskyn, Claudia I., et al.
Publicado: (2018)

Biomarkers in Post-kala-azar Dermal Leishmaniasis
por: Zijlstra, Eduard E.
Publicado: (2019)

Tissue Damage in Human Cutaneous Leishmaniasis: Correlations Between Inflammatory Cells and Molecule Expression
por: Saldanha, Maíra Garcia, et al.
Publicado: (2020)

Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites
por: Sghaier, Rabiaa M., et al.
Publicado: (2022)

Transforming Growth Factor Beta (TGFβ1) and Epidermal Growth Factor (EGF) as Biomarkers of Leishmania (V) braziliensis Infection and Early Therapeutic Response in Cutaneous Leishmaniasis: Studies in Hamsters
por: Montoya, Andrés, et al.
Publicado: (2018)

Leptomonas seymouri Co-infection in Cutaneous Leishmaniasis Cases Caused by Leishmania donovani From Himachal Pradesh, India
por: Thakur, Lovlesh, et al.
Publicado: (2020)

Unveiling drug-tolerant and persister-like cells in Leishmania braziliensis lines derived from patients with cutaneous leishmaniasis
por: Jara, Marlene, et al.
Publicado: (2023)

In Search of Biomarkers for Pathogenesis and Control of Leishmaniasis by Global Analyses of Leishmania-Infected Macrophages
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2018)

Phenotypic and Functional Profiles of Antigen-Specific CD4(+) and CD8(+) T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis
por: Egui, Adriana, et al.
Publicado: (2018)

Humoral response in Leishmaniasis
por: Conde, Luciana, et al.
Publicado: (2022)

Leishmania braziliensis Infection Enhances Toll-Like Receptors 2 and 4 Expression and Triggers TNF-α and IL-10 Production in Human Cutaneous Leishmaniasis
por: Polari, Ludmila P., et al.
Publicado: (2019)

Leishmania Exosomes/Extracellular Vesicles Containing GP63 Are Essential for Enhance Cutaneous Leishmaniasis Development Upon Co-Inoculation of Leishmania amazonensis and Its Exosomes
por: da Silva Lira Filho, Alonso, et al.
Publicado: (2022)

Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Downregulates the Inflammatory Response in Cutaneous Leishmaniasis Patients Without Interfering in Leishmania braziliensis Killing by Monocytes
por: Nascimento, Maurício T., et al.
Publicado: (2022)

Clinical Proteomics Profiling for Biomarker Identification Among Patients Suffering With Indian Post Kala Azar Dermal Leishmaniasis
por: Jaiswal, Priyank, et al.
Publicado: (2020)

The Presence of Leishmania braziliensis DNA in the Nasal Mucosa of Cutaneous Leishmaniasis Patients and the Search for Possible Clinical and Immunological Patterns of Disease Progression: A Cross Sectional Study
por: Barroso, Daniel Holanda, et al.
Publicado: (2021)

Isolation, characterization, and functional study of extracellular vesicles derived from Leishmania tarentolae
por: Shokouhy, Mehrdad, et al.
Publicado: (2022)

Editorial: Immunology and immunopathogenesis of human leishmaniasis
por: de Menezes, Juliana P. B., et al.
Publicado: (2022)

Genetics, Transcriptomics and Meta-Taxonomics in Visceral Leishmaniasis
por: Blackwell, Jenefer M., et al.
Publicado: (2020)

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
por: Samant, Mukesh, et al.
Publicado: (2021)

Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis
por: Marlais, Tegwen, et al.
Publicado: (2018)

Possible Diagnostic Improvement for Cutaneous Leishmaniasis: Is It Achievable?
por: Taslimi, Yasaman, et al.
Publicado: (2018)

Histological Disorganization of Spleen Compartments and Severe Visceral Leishmaniasis
por: Hermida, Micely d'El-Rei, et al.
Publicado: (2018)

Leishmaniasis Diagnosis via Metagenomic Next-Generation Sequencing
por: Chen, Hongbin, et al.
Publicado: (2020)

Apigenin is a promising molecule for treatment of visceral leishmaniasis
por: Emiliano, Yago S. S., et al.
Publicado: (2023)

Elucidating the role played by bone marrow in visceral leishmaniasis
por: Veras, Patricia Sampaio Tavares, et al.
Publicado: (2023)

Application of Quantitative PCR in the Diagnosis and Evaluating Treatment Efficacy of Leishmaniasis
por: Wu, Yun, et al.
Publicado: (2020)

Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
por: Zijlstra, Eduard E.
Publicado: (2021)

Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
por: Scariot, Debora B., et al.
Publicado: (2022)

Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
por: Romanelli, Maiara Maria, et al.
Publicado: (2019)

Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis
por: de Carvalho, Bruna Caroline, et al.
Publicado: (2022)

The Influence of Infection by Different Leishmania (Viannia) braziliensis Isolates on the Pathogenesis of Disseminated Leishmaniasis
por: Oliveira, Walker N., et al.
Publicado: (2021)

Replacement of Leishmania (Leishmania) infantum Populations in an Endemic Focus of Visceral Leishmaniasis in Brazil
por: Valdivia, Hugo O., et al.
Publicado: (2022)

High Anti-Leishmania IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis
por: de Lima, Clara Mônica F., et al.
Publicado: (2021)

GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis
por: Pomel, Sébastien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dlf4lap4cgj96gn5jga1gnkrmt